Page 1 of 1

the history of the invention and development of antibacterial drugs up

Posted: Mon Feb 03, 2025 3:46 am
by zakiyatasnim
CA-MRSA outbreaks and epidemics currently occur worldwide and have similar epidemiology, although the clones produced differ depending on geographic location.

The average length of stay in the hospital for patients with this infection is 76 days , and the cost of therapy is estimated at $33,500.

The global market for MRSA drugs was valued at $922 million in 2018. Coherent Market Insights analysts predict growth to $1.3 billion by 2026, mainly through improved formulations of already approved drugs.

In 2016, the pharmaceutical company Allergan received FDA approval taiwan number data to renew the Dalvance injection — a single dose administered intravenously over 30 minutes is sufficient to treat acute bacterial skin infections.

Such factors are expected to drive the growth of the MRSA hospital drug market. Another reason is the approval and launch of affordable drugs. For example, in 2015, Glenmark Pharmaceuticals was approved to manufacture a generic version of Zyvox, which is manufactured by the Norwegian company Fresenius Kabi Norge.



In the second part of the article, we will take a detailed look at to our time.